Wave Life Sciences Ltd (NASDAQ:WVE) has a beta value of -1.00 and has seen 1.55 million shares traded in the last trading session. The company, currently valued at $1.60B, closed the last trade at $10.40 per share which meant it gained $1.01 on the day or 10.76% during that session. The WVE stock price is -60.96% off its 52-week high price of $16.74 and 59.13% above the 52-week low of $4.25.
The consensus among analysts is that Wave Life Sciences Ltd (WVE) is Buy stock at the moment, with a recommendation rating of 1.18. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 3 have rated it as a Hold, with 3 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.25.
Wave Life Sciences Ltd (NASDAQ:WVE) trade information
Sporting 10.76% in the green in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the WVE stock price touched $10.40 or saw a rise of 9.25%. Year-to-date, Wave Life Sciences Ltd shares have moved -15.93%, while the 5-day performance has seen it change -7.39%. Over the past 30 days, the shares of Wave Life Sciences Ltd (NASDAQ:WVE) have changed -6.89%.
Wall Street analysts have a consensus price target for the stock at $22, which means that the shares’ value could jump 52.73% from current levels. The projected low price target is $15.0 while the price target rests at a high of $36.0. In that case, then, we find that the current price level is -246.15% off the targeted high while a plunge would see the stock gain -44.23% from current levels.
Wave Life Sciences Ltd (WVE) estimates and forecasts
The company’s shares have gained 102.73% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -33.82%.
9 analysts offering their estimates for the company have set an average revenue estimate of 11.28M for the current quarter. 9 have an estimated revenue figure of 14.28M for the next ending quarter. Year-ago sales stood 12.54M and 19.69M respectively for this quarter and the next, and analysts expect sales will shrink by -10.06% for the current quarter and -33.82% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 34.27% over the past 5 years. Earnings growth for 2025 is a modest -36.98% while over the next 5 years, the company’s earnings are expected to increase by 34.50%.
WVE Dividends
Wave Life Sciences Ltd is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Wave Life Sciences Ltd (NASDAQ:WVE)’s Major holders
The top two institutional holders are RA CAPITAL MANAGEMENT, L.P. with over 18.2 million shares worth more than $90.83 million. As of 2024-06-30, RA CAPITAL MANAGEMENT, L.P. held 14.0527% of shares outstanding.
The other major institutional holder is MAVERICK CAPITAL LTD, with the holding of over 7.67 million shares as of 2024-06-30. The firm’s total holdings are worth over $38.27 million and represent 5.9211% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are iShares Russell 2000 ETF and Primecap Odyssey Aggressive Growth Fund . As of Dec 31, 2024 , the former fund manager holds about 1.61% shares in the company for having 2.48 shares of worth $25.76 million while later fund manager owns 2.45 shares of worth $25.5 million as of Dec 31, 2024 , which makes it owner of about 1.60% of company’s outstanding stock.
